Cancer is a significant opportunity for the development of tissue engineering and cell therapies, but it is more than just an opportunity currently, since many companies are active and the market for cancer cell/tissue therapies already stands at nearly $500 million.
Currently, OSI Pharmaceuticals has a commanding lead in this area, with its Tarceva being [...]
Since the fundamental problem in Type 1 diabetes (or juvenile onset, diabetes mellitus) is that the islets cells in the pancreas no longer produce insulin (as opposed to Type 2 diabetes, in which the insulin produced is inadequate in form or amount), the solution to Type 1 is "simply" to replace this function. For all [...]
Diagnostic imaging technology taking hold in ophthalmology and other clinical applications…
(Below is an excerpt from spin-off analysis from the MedMarket Diligence report #G125, "Ophthalmology Worldwide: Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Diagnostic, Device and Drug Markets Worldwide, Forecasts 2004 – 2012." This spin-off analysis is provided as a deliverable when purchasing the complete report #G125.)
–
Optical [...]
Medical technology startup companies that we identified during the month of October 2009 are developing the following specific technologies:
Diagnostic imaging in urology and oncology.
Endoscopic tissue management technology.
Esophageal monitoring device to replace peripheral artery catheter.
Products for treatment of fecal incontinence and GERD.
Surgical instrumentation to reduce trauma of surgery.
Suction device for use in sleep breathing disorders.
Fully absorbable [...]
From InfraReDx, Inc.:
SAN FRANCISCO, Sept. 21 /PRNewswire/ — The TCT 2009 meeting will feature an unusual amount of novel information about Vulnerable Coronary Artery Plaque, the structure widely considered to be the primary cause of acute coronary events, the leading cause of death in the developed world. The concept of Vulnerable Plaque has been a [...]
Looking at the course of developments — in the healthcare reform "debate" (as it were) and medical technology — it is not a huge leap of judgment to make the following predictions for the ups and downs of healthcare overall and for specific medical technologies.
Predictions for the healthcare market
A healthcare reform package will pass this [...]
Foundation Medical Partners announced this week that it has raised $58.6 million toward a planned goal of $150 million for its Foundation Medical Partners III fund. The fund invests in medical device, biopharmaceutical and predictive medicine technology sectors.
As we previously noted in "equity overhang", there is now an aggregate of approximately of $400 million raised [...]
Below is a list of pending or recent reports from MedMarket Diligence.
COMING SOON
Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017
$4,250
(print or PDF; add $200 to receive both)
[...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.
Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective as [...]
As a follow up to a thread on Twitter that took place today regarding medtech, I thought I would just briefly post the number of examples of recent financings in medtech. Despite one part of conversation, when someone trotted out the old argument about how medtech needlessly contributes to rising healthcare costs (which was abruptly [...]
Contact:
